ARCHIMEDlife News

  • First LEA assay launched

    ARCHIMEDlife News March 14, 2018
    LEA2 MPS Panel Our first LEA2 (Lysosomal Enzyme Activity) assay has now been started and with it several mucopolysaccharidoses (MPS) can be diagnosed from one… Read more
  • Novel diagnostics for Rare Disorders: Fabry in females, presented at WorldSymposium

    ARCHIMEDlife News March 7, 2018
    The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients, otherwise women at risk might be… Read more
  • 5 years ARCHIMEDlife – Thanks to our partners, clients and friends!

    ARCHIMEDlife News November 21, 2017
    The 21st of November 2017  is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve a successful company with dedicated people… Read more
  • Become part of our readers´ community

    ARCHIMEDlife News November 12, 2017
    You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and rare diseases – first hand and… Read more
  • We were there: Asia-Pacific Conference on Human Genetics

    ARCHIMEDlife News November 6, 2017
    We took part in the 12th Asia-Pacific Conference on Human Genetics “Genomic Medicine and Clinical Practice” from 8th to 10th of November in Bangkok. Medical… Read more
  • Pharmaboardroom.com: Interview with ARCHIMEDlife CEO David Kasper in Austria issue of “Healthcare and Life Sciences Review”

    ARCHIMEDlife News October 16, 2017
    Pharmaboardroom.com interviewed ARCHIMEDlife CEO David Kasper for their latest Austria issue of “Healthcare and Life Sciences Review”. Find out why he founded ARCHIMEDlife in a… Read more